273 related articles for article (PubMed ID: 30713294)
21. Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.
Ejima-Yamada K; Oshiro Y; Okamura S; Fujisaki T; Mihashi Y; Tamura K; Fukushige T; Kojima M; Shibuya K; Takeshita M
Virchows Arch; 2017 Feb; 470(2):205-215. PubMed ID: 27864689
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus-related MTX-LPD in rheumatoid arthritis patients exhibits a viral pattern of the CD64 and CD35 expression on neutrophils: three case reports.
Mokuda S; Miyazaki T; Saeki Y; Masumoto J; Kanno M; Takasugi K
Mod Rheumatol; 2015 Jan; 25(1):166-8. PubMed ID: 24499448
[No Abstract] [Full Text] [Related]
23. Oral Methotrexate-related Lymphoproliferative Disease Presenting with Severe Osteonecrosis of the Jaw: A Case Report and Literature Review.
Furukawa S; Oobu K; Moriyama M; Kawano S; Sako S; Hayashida JN; Matsubara R; Ogata KI; Kiyoshima T; Nakamura S
Intern Med; 2018 Feb; 57(4):575-581. PubMed ID: 29225245
[TBL] [Abstract][Full Text] [Related]
24. Endobronchial Manifestation of Methotrexate-induced Lymphoproliferative Disorder.
Ikeue T; Kawachi H; Yoshida H; Tanaka E; Noguchi S; Fukao A; Terashita S; Tajiri T; Horikawa S; Sugita T
Intern Med; 2019 Jun; 58(11):1597-1603. PubMed ID: 30713318
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis: Clinicopathologic Features and Prognostic Factors.
Kurita D; Miyoshi H; Ichikawa A; Kato K; Imaizumi Y; Seki R; Sato K; Sasaki Y; Kawamoto K; Shimono J; Yamada K; Muto R; Kizaki M; Nagafuji K; Tamaru JI; Tokuhira M; Ohshima K
Am J Surg Pathol; 2019 Jul; 43(7):869-884. PubMed ID: 31116708
[TBL] [Abstract][Full Text] [Related]
26. Large ulceration of the oropharynx induced by methotrexate-associated lymphoproliferative disorders.
Hanakawa H; Orita Y; Sato Y; Uno K; Nishizaki K; Yoshino T
Acta Med Okayama; 2013; 67(4):265-9. PubMed ID: 23970326
[TBL] [Abstract][Full Text] [Related]
27. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.
Salloum E; Cooper DL; Howe G; Lacy J; Tallini G; Crouch J; Schultz M; Murren J
J Clin Oncol; 1996 Jun; 14(6):1943-9. PubMed ID: 8656264
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical Assessment of the Diagnostic Utility of PD-L1 (Clone SP142) for Methotrexate-Associated Lymphoproliferative Disorders With an Emphasis of Neoplastic PD-L1 (Clone SP142)-Positive Classic Hodgkin Lymphoma Type.
Kohno K; Suzuki Y; Elsayed AA; Sakakibara A; Takahara T; Satou A; Kato S; Nakamura S; Asano N
Am J Clin Pathol; 2020 Apr; 153(5):571-582. PubMed ID: 31977037
[TBL] [Abstract][Full Text] [Related]
29. Intracranial Methotrexate-Associated Lymphoproliferative Disorder in Rheumatoid Arthritis.
Miyaza S; Matsuda R; Nakamura M; Nakagawa I; Motoyama Y; Nakase H
World Neurosurg; 2019 Oct; 130():138-141. PubMed ID: 31295614
[TBL] [Abstract][Full Text] [Related]
30. [EBV-positive MTX-associated lymphoproliferative disorder and Ig M myeloma in rheumatoid arthritis].
Wernecke M; Frieling D; Brandl U; Feller A; von Wichert G
Dtsch Med Wochenschr; 2021 Feb; 146(4):262-265. PubMed ID: 33592662
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.
Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
Int J Clin Exp Pathol; 2013; 6(10):2237-41. PubMed ID: 24133604
[TBL] [Abstract][Full Text] [Related]
32. Methotrexate-associated lymphoproliferative disorder mimicking pyocyanic ecthyma gangrenosum in a patient with rheumatoid arthritis.
Inuzuka K; Endo Y; Kato M; Fujisawa A; Tanioka M; Kabashima K; Tsukamoto H; Sonobe J; Bessho K; Miyachi Y
Eur J Dermatol; 2013; 23(3):418-9. PubMed ID: 23783770
[No Abstract] [Full Text] [Related]
33. Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients.
Saito S; Takeuchi T
J Clin Exp Hematop; 2019; 59(4):145-155. PubMed ID: 31866617
[TBL] [Abstract][Full Text] [Related]
34. [Three cases of methotrexate-associated lymphoproliferative disorder (MTX-LPD)].
Ishida Y; Asahi A; Wada T; Kanai N; Kobayashi Y; Moriai S; Kishibe K; Harabuchi Y
Nihon Jibiinkoka Gakkai Kaiho; 2008 Aug; 111(8):594-8. PubMed ID: 18788425
[TBL] [Abstract][Full Text] [Related]
35. Methotrexate-related lymphoproliferative disorder of the lumbar spine origin presenting with severe low-back pain: case report.
Kikuchi N; Uesugi M; Koda M; Shimizu T; Murakami K; Kono M; Tanaka H; Yamazaki M
J Neurosurg Spine; 2018 Nov; 29(5):545-548. PubMed ID: 30168781
[TBL] [Abstract][Full Text] [Related]
36. Methotrexate-associated lymphoproliferative disorders of the tongue developing in patients with rheumatoid arthritis: a report of 2 cases and a review.
Hashimoto K; Nagao T; Saito T; Kinoshita H
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):e1-5. PubMed ID: 24927637
[TBL] [Abstract][Full Text] [Related]
37. Association of higher methotrexate dose with lymphoproliferative disease onset in rheumatoid arthritis patients.
Kameda T; Dobashi H; Miyatake N; Inoo M; Onishi I; Kurata N; Mitsunaka H; Kawakami K; Fukumoto T; Susaki K; Izumikawa M; Nakashima S; Shimada H; Takeuchi Y; Haba R; Mano S; Onishi H; Imataki O; Matsunaga T
Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1302-9. PubMed ID: 24515570
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary and retroperitoneal lesions induced by methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis.
Yamakawa H; Yoshida M; Katagi H; Hirooka S; Okuda K; Ishikawa T; Takagi M; Kuwano K
Mod Rheumatol; 2016; 26(3):441-4. PubMed ID: 24684409
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus-associated lymphoproliferative disorder in a patient with rheumatoid arthritis on methotrexate and rofecoxib: idiosyncratic reaction or pharmacogenetics?
Vincent S; Slease RB; Rocca PV
Del Med J; 2002 Dec; 74(12):469-73. PubMed ID: 15595320
[TBL] [Abstract][Full Text] [Related]
40. Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: A review of the literature and current perspective.
Harigai M
Mod Rheumatol; 2018 Jan; 28(1):1-8. PubMed ID: 28758827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
